Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours

erbB receptors consist of three components: the extracellular domain to which ligands bind; a transmembrane domain; and an intracellular domain that includes tyrosine kinase.


		Next»

Return to Project